Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × dactolisib × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1 CNS 1

Conditions

Neuroendocrine Tumors 2 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3 Fluorodeoxyglucose F18 2 FAPI-46 2 fluorodopa F 18 1 entrectinib 1 dactolisib 1 Specimen Handling 1 Respiratory Therapy 1 Furosemide 1 Everolimus 1 4-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01508104 2017-08-23

Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

University of Cincinnati

Phase 1 Terminated

CNSEndocrineNET

Brain Neoplasms, Glioblastoma, Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡